Unlock instant, AI-driven research and patent intelligence for your innovation.

Processes for preparing (1 -(3-fluoro-2-(trifluoromethyl)isonicotinyl)piperidine-4-one)

A technology of piperidone and hydroxypiperidine, applied in the field of preparation of (1-(3-fluoro-2-(trifluoromethyl)isonicotinyl)piperidin-4-one), can solve uncontrollable bleeding , do not want and other issues

Active Publication Date: 2020-12-18
INCYTE CORP
View PDF12 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

This can cause unwanted and / or uncontrollable bleeding

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Processes for preparing (1 -(3-fluoro-2-(trifluoromethyl)isonicotinyl)piperidine-4-one)
  • Processes for preparing (1 -(3-fluoro-2-(trifluoromethyl)isonicotinyl)piperidine-4-one)
  • Processes for preparing (1 -(3-fluoro-2-(trifluoromethyl)isonicotinyl)piperidine-4-one)

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0039] The preparation of compounds may involve the protection and deprotection of a variety of chemical groups. The need for protecting and deprotecting groups and selection of appropriate protecting groups are readily determined by those skilled in the art. The chemistry of protecting groups can be found, for example, in Greene et al., Protective Groups in Organic Synthesis, 4th Edition, Wiley & Sons, 2007, which is hereby incorporated by reference in its entirety. Modifications of protecting groups and methods of formation and cleavage described herein can be tailored as desired for a variety of substituents.

[0040] The reactions of the methods described herein can be carried out in suitable solvents readily selected by those skilled in the art of organic synthesis. Suitable solvents may be substantially non-reactive with the starting materials (reactants), intermediates or products at the temperatures at which the reactions are carried out, eg, may be at temperatures ra...

Embodiment 1

[0146] Example 1. Synthesis of 2-(3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(1-(3- Fluoro-2-(trifluoromethyl)isonicotinyl)piperidin-4-yl)azetidin-3-yl)acetonitrile adipate (9)

[0147] Option I

[0148]

[0149]3-(cyanomethyl)-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole-1 -yl) azetidine-1-carboxylic acid tert-butyl ester (3). To a 1 L flask equipped with a nitrogen inlet, a thermocouple and a mechanical stirrer was added sequentially isopropanol (IPA, 200 mL) at ambient temperature, 1,8-diazabicyclo[5,4,0]undec-ene (DBU, 9.8g, 64.4mmol, 0.125 equivalents), 4-(4,4,5,5-tetramethyl-1,3 , 2-dioxaborolan-2-yl)-1H-pyrazole (1,101 g, 520.51 mmol, 1.01 equiv) and tert-butyl 3-(cyanomethylene)azetidine-1-carboxylate Ester (2, 100 g, 514.85 mmol), resulting in the reaction mixture as a suspension. The resulting reaction mixture was heated to reflux over 30 minutes to obtain a homogeneous solution and the mixture was maintained at reflux for an ...

Embodiment 2

[0154] Example 2: 2-(3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(1-(3-fluoro Alternative Synthesis of -2-(Trifluoromethyl)isonicotinyl)piperidin-4-yl)azetidin-3-yl)acetonitrile

[0155] Scheme II

[0156]

[0157] 2-(Azetidine-3-ylidene)acetonitrile hydrochloride (2a). To a 0.5 L flask equipped with nitrogen inlet, thermocouple and mechanical stirrer was added 3-(cyanomethylene base) tert-butyl azetidine-1-carboxylate (2, 30 g, 154.46 mmol) and dichloromethane (300 mL). The solution was then treated with 5M hydrogen chloride (HCl) in isopropanol (294.2 mL, 1.54 mol, 10 equiv) at ambient temperature and the resulting reaction mixture was stirred at ambient temperature for 18 hours. After the reaction was complete as monitored by HPLC, tert-butyl methyl ether (TBME, 150 mL) was added to the suspension, and the mixture was stirred at ambient temperature for 2 hours. The solid was collected by filtration, washed with n-heptane (2 x 100 mL), and dried on the ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

This invention relates to processes and intermediates for making {1- {l-[3-fluoro-2-(trifluoromethyl)isonicotinoyl]piperidin-4-yl}-3-[4-(7H- pyrrolo[2,3-d]pyrimidin-4-yl)-IH-pyrazol-l-yl]azetidin-3-yl}acetonitrile, useful in the treatment of diseases related to the activity of Janus kinases (JAK) including inflammatory disorders, autoimmune disorders, cancer, and other diseases. The invention is specifically directed to processes for making the intermediate (l-(3-fluoro-2- (trifluoromethyl)isonicotinyl)piperidine-4-one) from l-(3-fluoro-2- (trifluoromethyl)isonicotinoyl chloride and 4-hydroxypiperidine or 4- piperidone as well as to the intermediate l-(3-fluoro-2-(trifluoromethyl)isonicotinoyl chloride.

Description

technical field [0001] The present invention relates to the preparation of {1-{1-[3-fluoro-2-(trifluoromethyl)isonicotinyl]piperidin-4-yl}-3-[4-(7H-pyrrolo[2,3 -d] methods and intermediates of pyrimidin-4-yl)-1H-pyrazol-1-yl]azetidin-3-yl}acetonitrile, said compounds being useful in the treatment of Janus kinase (JAK) activity-related diseases, including inflammatory disorders, autoimmune disorders, cancer, and others. Background technique [0002] Protein kinases (PKs) regulate various biological processes, including cell growth, survival, differentiation, organ formation, morphogenesis, neovascularization, tissue repair and regeneration, among others. Protein kinases also play specialized roles in many human diseases, including cancer. Cytokines, low molecular weight polypeptides or glycoproteins regulate many pathways related to the host inflammatory response to sepsis. Cytokines affect cell differentiation, proliferation, and activation, and can modulate pro- and anti...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D401/04C07D213/61
CPCC07D401/04C07D213/61C07D401/06C07D487/04C07D213/803A61P27/02A61P17/06A61P19/02A61P19/08A61P35/00A61K31/4545A61P29/00A61P37/00
Inventor D·王P·刘Y·吴J·周
Owner INCYTE CORP